Similarly, recent reports indicate that in DCIS, a high density of immunosuppressive FOXP3+TIL cells was associated with the HER2-positive subtype, microinvasion, and high grade, and, consequently, was prognostic of an increased risk of recurrence [25,35,45]. The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.